🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
the cyclosporine showed efficacy in many immune cytopenic diseases in the l...
Status
Recruiting
Location
Assiut university hospital
Start Date
2021-10-20
Trial ID
NCT05057468
Treatments Being Tested
This study is designed to investigate the efficacy and safety of allogeneic...
Status
Unknown
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2015-11
Trial ID
NCT02563340
Treatments Being Tested
This is a Phase III, randomized, double-blind, double-dummy, active-compara...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2015-05-26
Trial ID
NCT02383589
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
A total of 506 patients, 253 per arm, will be enrolled at 30 to 40 sites in...
Status
Unknown
Location
Northside Hospital
Start Date
2004-04
Trial ID
NCT00078598
Treatments Being Tested
Post-transplantation lymphoproliferative disorder (PTLD) develops in one to...
Status
Terminated
Location
Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Qld 4102
Start Date
2002-12
Trial ID
NCT01458548
Interstitial lung disease (ILD) is characterised by inflammation and scarri...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2014-11
Trial ID
NCT01862926
Treatments Being Tested
This is a randomized, multi-center, open-label Phase II clinical trial to d...
Status
Withdrawn
Location
Geisinger Medical Center
Start Date
2012-09
Trial ID
NCT01524068
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447